The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.

The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.

The human CD44 cell surface glycoprotein family which has been implicated in lymphocyte homing, tumor metastasis, and extracellular matrix attachment consists of a large number of related isoforms that derive from the differential splicing of a single CD44 gene transcript. Recent mapping of the CD44...

Bibliografske podrobnosti
Main Authors:	Screaton, G, Bell, M, Bell, J, Jackson, D
Format:	Journal article
Jezik:	English
Izdano:	1993

Podobne knjige/članki

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
od: Screaton, G, et al.
Izdano: (1992)

Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
od: Jackson, D, et al.
Izdano: (1995)

THE STRUCTURE OF THE GENE ENCODING THE ALTERNATIVELY SPLICED CD44 GLYCOPROTEIN
od: Jackson, D, et al.
Izdano: (1993)

Conservation of exon scrambling in human and mouse
od: Hamilton, Monica L. (Monica Lauren)
Izdano: (2012)

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
od: Bennett, K, et al.
Izdano: (1995)

CD44 and cancer.
od: Jackson, D, et al.
Izdano: (1993)

Conservation of CD44 exon v3 functional elements in mammals
od: Fernández-Bellon Hugo, et al.
Izdano: (2008-07-01)

THE GENOMIC ORGANIZATION OF THE HUMAN CD44 GENE
od: Bell, M, et al.
Izdano: (1993)

Exon Amplification Restriction Ligation (EARL): An Efficient Strategy for Direct Sequencing of Exons
od: Peter Bugert, et al.
Izdano: (2001-03-01)

CD44 variant exons induce chemoresistance by modulating cell death pathways
od: Maria Yanova, et al.
Izdano: (2025-03-01)

Exon organization and novel alternative splicing of Ank3 in mouse heart.
od: Gokay Yamankurt, et al.
Izdano: (2015-01-01)

In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
od: Aoki, Y, et al.
Izdano: (2010)

Specificity of 6th Workshop CD44 panel antibodies for alternatively spliced exons and their effects on lymphocyte activation and hyaluronan binding.
od: Bannerji, S, et al.
Izdano: (1996)

CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
od: Bennett, K, et al.
Izdano: (1995)

Exonization of active mouse L1s: a driver of transcriptome evolution?
od: Badge Richard, et al.
Izdano: (2007-10-01)

CD44 and cancer screening.
od: Fox, S, et al.
Izdano: (1993)

Exon skipping is correlated with exon circularization
od: Kelly, S, et al.
Izdano: (2015)

Exon-Mediated Activation of Transcription Starts
od: Fiszbein, Ana, et al.
Izdano: (2021)

Exon-Mediated Activation of Transcription Starts
od: Fiszbein, Ana, et al.
Izdano: (2022)

CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice.
od: Hirano, H, et al.
Izdano: (1994)

ExonSurfer: a web-tool to design primers at exon–exon junctions
od: Pablo Monfort-Lanzas, et al.
Izdano: (2024-06-01)

Genes adapt to outsmart gene-targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation
od: Vishnu Hosur, et al.
Izdano: (2020-07-01)

DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.
od: Joji Iida, et al.
Izdano: (2014-01-01)

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
od: Lu, Q, et al.
Izdano: (2003)

Exon tethering in transcription by RNA polymerase II.
od: Dye, M, et al.
Izdano: (2006)

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
od: Annemieke Aartsma-Rus
Izdano: (2022-12-01)

Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays
od: Yeh Ru-Fang, et al.
Izdano: (2008-11-01)

The emergence of alternative 3' and 5' splice site exons from constitutive exons.
od: Eli Koren, et al.
Izdano: (2007-05-01)

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
od: Lu, Q, et al.
Izdano: (2004)

Exon skipping peptide-pmos for correction of dystrophin in mouse models of duchenne muscular dystrophy
od: Betts, C, et al.
Izdano: (2014)

Novel EGFP reporter cell and mouse models for sensitive imaging and quantification of exon skipping
od: Hara, Y, et al.
Izdano: (2020)

Characterising a homozygous two‐exon deletion in UQCRH: comparing human and mouse phenotypes
od: Silvia Vidali, et al.
Izdano: (2021-11-01)

Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models
od: Amel Saoudi, et al.
Izdano: (2023-03-01)

Exon and junction microarrays detect widespread mouse strain- and sex-bias expression differences
od: Schadt Eric E, et al.
Izdano: (2008-06-01)

Functional importance of different patterns of correlation between adjacent cassette exons in human and mouse
od: Zhang Xuegong, et al.
Izdano: (2008-04-01)

MicroExonator enables systematic discovery and quantification of microexons across mouse embryonic development
od: Guillermo E. Parada, et al.
Izdano: (2021-01-01)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
od: Kane L Greer, et al.
Izdano: (2014-01-01)

A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
od: Ridout, C, et al.
Izdano: (2008)

Abundance of clinical variants in exons included in multiple transcripts
od: Sankar Subramanian
Izdano: (2018-06-01)

Discovery and characterization of human exonic transcriptional regulatory elements.
od: Arshad H Khan, et al.
Izdano: (2012-01-01)